AI in Healthcare
The latest on artificial intelligence transforming medicine
News stories discovered and organized by an automated pipeline. Covering clinical deployments, research breakthroughs, regulation, and industry developments.
Lunit Targets U.S. Breast Cancer Risk Market After NCCN Guideline Update
Korea Biomedical reports that Lunit is eyeing the U.S. breast cancer risk market after an NCCN guideline update. The shift illustrates how guideline changes can quickly reshape commercial opportunities for AI health technology.
Breast Cancer Screening Is Moving Toward AI-Based Risk Assessment
MSN reports that global experts want breast cancer screening guidelines to incorporate AI-based risk assessments. The idea reflects a broader shift from one-size-fits-all screening toward more personalized pathways that can better match screening intensity to an individual’s risk.
Global Breast Cancer Screening Guidelines Begin to Embrace AI-Based Risk Assessment
Global experts are reportedly recommending that breast cancer screening guidelines include AI-based risk assessments. The move suggests AI is shifting from a tool that reads images to one that helps decide who should be screened, when, and how often.
Global Screening Guidelines Are Starting to Fold AI Risk Assessment Into Breast Cancer Care
Global experts are reportedly updating breast cancer screening guidance to include AI-based risk assessments. That is a notable move from using AI as an imaging assistant to treating it as part of formal prevention strategy.
AI Risk Models Could Change Breast Cancer Screening Before the First Scan
An academic report argues AI is becoming central to breast cancer diagnosis and treatment, reinforcing a broader move toward risk-based screening. The story matters because AI is increasingly shaping who gets screened, not just how scans are read.
AI Breast Cancer Risk Guidelines Signal a Shift From Detection to Prevention
New guidelines recommending AI-based breast cancer risk assessment mark a major change in how breast care may be organized. Instead of using AI only to read images, clinicians are beginning to consider it as part of risk stratification and screening decisions.
New Breast Cancer Risk Guidelines Put AI in the Screening Pathway
New guidelines recommend AI-based breast cancer risk assessments, a notable signal that risk modeling is moving closer to mainstream screening. The recommendation could influence who gets earlier follow-up, more intensive surveillance, or preventive interventions.
Breast Imaging AI Moves Into the Guideline Era as Clairity Breast Gets NCCN Recognition
Clairity Breast's addition to NCCN guidelines marks an important milestone for AI-based breast cancer risk assessment, signaling that artificial intelligence is beginning to influence standard screening pathways rather than sitting on the experimental fringe. The move could accelerate adoption of image-based risk stratification, especially for women who might otherwise be missed by traditional approaches.
How this works
Discover
An automated pipeline searches the web for significant AI healthcare news across clinical, research, regulatory, and industry domains.
Structure
The pipeline turns source material into concise, readable stories with categories, tags, and context that make the feed easier to scan.
Publish
Stories are deduplicated, stored, and published to this site. The pipeline runs automatically to keep coverage current.